GS-649443

N/A

Report date: 2023/02/11 20:38:33

NME

Base Information

Drug NameGS-649443

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors

TargetsPhosphatidylinositol 3 kinase delta

Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGilead Sciences Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma

ATC CodeN/A